A multistate outbreak of extensively drug-resistant Salmonella infections has been linked to Rosabella brand moringa powder capsules, prompting a recall and health alerts from the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA). As of February 13, 2026, seven people across seven states have been sickened, with three hospitalizations reported, but no deaths.
The CDC investigation revealed the Salmonella strain responsible for the outbreak exhibits resistance to multiple antibiotics commonly used to treat Salmonella infections, potentially complicating treatment options. According to the CDC, this strain shows predicted resistance or nonsusceptibility to amoxicillin-clavulanic acid, ampicillin, azithromycin, cefoxitin, ceftiofur, ceftriaxone, chloramphenicol, ciprofloxacin, gentamicin, hygromycin, kanamycin, meropenem, streptomycin, sulfisoxazole, and tetracycline.
The affected product has been identified as specific lots of Rosabella brand moringa powder capsules distributed by Ambrosia Brands LLC. The capsules are sold in white plastic bottles with a green label, with 52 lot codes and expiration dates in 2027. Distribution has been primarily online through the company’s website (tryrosabella.com), Amazon, TikTok Shop, Shein, and eBay, as well as through links on social media platforms like Facebook.
Health officials are advising consumers to immediately discontinue employ of the recalled capsules and either discard them or return them to the place of purchase. The CDC and FDA similarly recommend thoroughly washing any surfaces and items that may have come into contact with the capsules using hot, soapy water or a dishwasher.
This is the second Salmonella outbreak linked to moringa powder in recent months, though the CDC states the two outbreaks are not related. A previous investigation into a Salmonella outbreak linked to dietary supplements containing moringa leaf powder was updated in January 2026.
Symptoms of Salmonella infection typically include diarrhea, fever, and stomach cramps, appearing six to six days after exposure. Although most individuals recover within four to seven days, severe cases can require hospitalization. Young children, older adults, and individuals with weakened immune systems are at higher risk of severe illness.
The Washington State Department of Health has reported one confirmed case within the state, a resident of King County. State and local health departments are continuing to investigate and monitor the situation.
The FDA is conducting further investigation to determine if additional products are contributing to the outbreak. Consumers with concerns or questions about potential exposure are encouraged to contact their healthcare provider.
